IMO You are correct in all of your conclusions. There does seem to be problems finding testable patients. To me that screems out that there are also not enough people in the market to make that product profitable. Refocusing on a different treatment seems essential at this point. As I understand it this is a delivery system not the actual drug.
News 
Market Data 
Discover 
